Sunrase Life Science Private Limited
About Sunrase Life Science Private Limited
Data last updated:
Sunrase Life Science Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 04 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24230UP2019PTC124108. Its GSTIN is 09ABDCS0148L1Z5 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sunil Kulshrestha and Shikha Kulshrestha.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Pl. No. R 53 Shiva Enclave Mauza Baipur Mustkil, Agra, Uttar Pradesh, India – 282007.
As per the financials filed for FY 2023, the company reported a revenue of ₹17.07 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹609 (net margin 0%) and EBITDA of -₹609 (EBITDA margin 0%).
Company details
Contact details
Sunrase Life Science Private Limited's registered office is in Agra, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPl. No. R 53 Shiva Enclave Mauza Baipur Mustkil, Agra, Uttar Pradesh, India – 282007
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Sunrase Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sunrase Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sunrase Life Science Private Limited, buy the company report.
Financials of Sunrase Life Science Private Limited
FY 2023 filings availableSunrase Life Science Private Limited reported revenue of ₹17.07 Lakh (up 322% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 322% in the latest year. EBITDA rose 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹609 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹609 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0% | |||
| Net Profit Margin | 0% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sunrase Life Science Private Limited, buy the company report.
Board of directors of Sunrase Life Science Private Limited
Sunrase Life Science has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kulshrestha Also directs: Soumitri Healthcare Private Limited | Director | 04 Dec 2019 | 6 Years 10 Months | Current |
| Shikha Kulshrestha | Additional Director | 12 Feb 2022 | 4 Years 8 Months | Current |
| Kajal Kulshrestha | Additional Director | 12 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Sunrase Life Science Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aprameya Chemical & Rubber Private Limited | ₹17.13 Lakh (FY 2024) | 1611.0% | Anklesver, Gujarat, India | |||
| Metsun Pharma India Private Limited | ₹17.11 Lakh (FY 2018) | Aurangabad, Maharashtra, India | ||||
| Xenon Laboratories Private Limited | ₹17.1 Lakh (FY 2025) | 14.0% | Chandigarh, India | |||
| Aries Micro Nutrients (India) Private Limited | ₹17.09 Lakh (FY 2025) | -35.0% | Hyderabad, Telangana, India | |||
| V.R.Surgiplast Private Limited | ₹17.09 Lakh (FY 2015) | 156.0% | Gwalior, Madhya Pradesh, India | |||
| Sunrase Life Science Private Limitedthis company | ₹17.07 Lakh (FY 2023) | -₹609 | 0% | 322.0% | Agra, Uttar Pradesh, India | |
| Hridayam Pharmaceuticals Private Limited | ₹17.05 Lakh (FY 2023) | 26.0% | Zundal, Gujarat, India | |||
| Pearl Silicon Products Private Limited | ₹17.03 Lakh (FY 2025) | 66.0% | Ponneri, Tamil Nadu, India | |||
| Dravya Aushadhi India Limited | ₹17.02 Lakh (FY 2025) | -75.0% | Karnal, Haryana, India | |||
| Cdci Pharma Private Limited | ₹17 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| Bioartis Life Sciences Private Limited | ₹16.99 Lakh (FY 2020) | -37.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sunrase Life Science Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sunrase Life Science Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunrase Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sunrase Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09ABDCS0148L1Z5 | Uttar Pradesh | Active | 31 Dec 2019 |
To see the full GST registrations and return filing status of Sunrase Life Science Private Limited, buy the company report.
Recent activity
Sunrase Life Science Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Kajal Kulshrestha was appointed as Additional Director on 12 Feb 2022.
Frequently asked questions
Sunrase Life Science is an active private limited company based in Agra, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 04 December 2019 (7+ years old) and is registered under CIN U24230UP2019PTC124108.
Sunrase Life Science has 3 current directors:
- Sunil Kulshrestha - Director
- Shikha Kulshrestha - Additional Director
- Kajal Kulshrestha - Additional Director
The latest financial statements of Sunrase Life Science on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Sunrase Life Science is 09ABDCS0148L1Z5, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Sunrase Life Science is U24230UP2019PTC124108. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunrase Life Science was incorporated on 04 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Sunrase Life Science by revenue are Aprameya Chemical & Rubber Private Limited, Metsun Pharma India Private Limited, Xenon Laboratories Private Limited, Aries Micro Nutrients (India) Private Limited, V.R.Surgiplast Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kajal Kulshrestha was appointed as Additional Director on 12 Feb 2022. Shikha Kulshrestha was appointed as Additional Director on 12 Feb 2022. Vijay Goyal ceased to be Director on 12 Feb 2022. Sunrase Life Science has 4 board changes on record in total.
The registered office of Sunrase Life Science is at Pl. No. R 53 Shiva Enclave Mauza Baipur Mustkil, Agra, Uttar Pradesh, India – 282007.
Sunrase Life Science operates in the chemicals industry, in the manufacturing segment.
Sunrase Life Science can be reached at its registered office: Pl. No. R 53 Shiva Enclave Mauza Baipur Mustkil, Agra, Uttar Pradesh, India – 282007.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
